This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
The outcome and results are attached herewith. Further, the management has deferred the agenda of increase in authorized capital and raising of funds by way of preferential issue
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.7 pts more than Nifty Microcap 250 and 1.2 pts more than its Non Banking Financial Company (NBFC) peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Bazel International Ltd, a registered NBFC, held its board meeting on 28th May 2025 and approved audited standalone and consolidated financial results for Q4 and FY ended 31st March 2025. The statutory auditor issued an unmodified (clean) opinion on the results. On a standalone basis, total revenue from operations fell sharply to Rs 243.40 lakhs in FY25 from Rs 1,778.75 lakhs in FY24 — an ~86% decline — mainly because a one-time Rs 1,539.64 lakh gain from derecognition of financial assets in the previous year did not repeat. Despite the revenue drop, standalone net profit rose strongly to Rs 99.12 lakhs from Rs 35.55 lakhs, though EPS fell to Rs 0.39 from Rs 1.87 due to a higher equity base (paid-up capital increased from Rs 195.05 lakhs to Rs 278.6 lakhs of shares). Consolidated net profit was nearly flat at Rs 35.24 lakhs vs Rs 35.55 lakhs. The board appointed Mr. Vivek Singh as Internal Auditor for FY26 and re-appointed M/s Meenu G & Associates as Secretarial Auditor for 5 years. Notably, the management deferred its earlier agenda to increase authorized capital and raise funds via a preferential issue, signalling a pull-back from the planned fundraising. Operating cash flow was deeply negative at Rs (812.64) lakhs standalone and Rs (945.98) lakhs consolidated, showing a sharp worsening from the prior year.
The deferred capital raise may ease near-term dilution pressure but removes a potential growth-funding avenue, which investors should watch. The steep revenue decline (driven by absence of a one-off gain) alongside deeply negative operating cash flows despite higher reported profits is a mixed signal — short-term profitability has improved, but core cash generation has weakened significantly, which could weigh on the stock.
| Q4 FY25 | Q4 FY24 | Change | |
|---|---|---|---|
| Revenue | ₹2.43 Cr | ₹13.99 Cr | −82.6% |
| Operating profit | ₹0.63 Cr | ₹1.55 Cr | −59.1% |
| Profit after tax | ₹0.99 Cr | ₹2.20 Cr | −55.0% |
| EBITDA margin | 43.9% | 13.5% | +30.4 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.